Genetically modified organisms (GMOs) have the potential to help prevent the spread of diseases and increase both crop yields and nutritional value, but according to an article in Science Alert, "There's a big problem. . . . When you release altered species out into the wild, how can you prevent them from breeding with untweaked organisms living in their natural environment, and producing hybrid offspring that scientists can't control or regulate?" Synthetic biologist Maciej Maselko of the BioTechnology Institute, a Consortium member, is leading a team to solve this problem. Prof. Maselko's researchers have used the gene editing tool CRISPR-Cas9 to alter yeast microbes so they're genetically incompatible and incapable of mating with their non-GMO counterparts. They call this approach "synthetic incompatability," and it's a technique that could be used in a multitude of ways, including to curb invasive carp or increase the production of medicines derived from plants. Read the entire article here.
The Minnesota Precision Medicine Collaborative (MPMC) is a transformative initiative to use 21st century technologies – including genomics, informatics, bioengineering, analysis of environmental exposures, and behavioral sciences – to tailor health care to the challenges facing individuals and their communities.